chr22-36284668-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002473.6(MYH9):​c.5484-157G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0411 in 152,208 control chromosomes in the GnomAD database, including 133 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.041 ( 133 hom., cov: 33)

Consequence

MYH9
NM_002473.6 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.871

Publications

3 publications found
Variant links:
Genes affected
MYH9 (HGNC:7579): (myosin heavy chain 9) This gene encodes a conventional non-muscle myosin; this protein should not be confused with the unconventional myosin-9a or 9b (MYO9A or MYO9B). The encoded protein is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain which is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in this gene have been associated with non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness. [provided by RefSeq, Dec 2011]
MYH9 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 17
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • May-Hegglin anomaly
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 22-36284668-C-T is Benign according to our data. Variant chr22-36284668-C-T is described in ClinVar as Benign. ClinVar VariationId is 1225120.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0518 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH9NM_002473.6 linkc.5484-157G>A intron_variant Intron 38 of 40 ENST00000216181.11 NP_002464.1 P35579-1A0A024R1N1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH9ENST00000216181.11 linkc.5484-157G>A intron_variant Intron 38 of 40 1 NM_002473.6 ENSP00000216181.6 P35579-1

Frequencies

GnomAD3 genomes
AF:
0.0412
AC:
6262
AN:
152090
Hom.:
133
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0271
Gnomad AMI
AF:
0.0296
Gnomad AMR
AF:
0.0204
Gnomad ASJ
AF:
0.0429
Gnomad EAS
AF:
0.0572
Gnomad SAS
AF:
0.0539
Gnomad FIN
AF:
0.0515
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0509
Gnomad OTH
AF:
0.0379
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0411
AC:
6263
AN:
152208
Hom.:
133
Cov.:
33
AF XY:
0.0405
AC XY:
3012
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0271
AC:
1124
AN:
41524
American (AMR)
AF:
0.0203
AC:
310
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0429
AC:
149
AN:
3470
East Asian (EAS)
AF:
0.0571
AC:
296
AN:
5182
South Asian (SAS)
AF:
0.0535
AC:
258
AN:
4822
European-Finnish (FIN)
AF:
0.0515
AC:
547
AN:
10612
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0508
AC:
3458
AN:
68008
Other (OTH)
AF:
0.0398
AC:
84
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
323
646
968
1291
1614
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0299
Hom.:
26
Bravo
AF:
0.0376
Asia WGS
AF:
0.0720
AC:
248
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Dec 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.097
DANN
Benign
0.66
PhyloP100
-0.87
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071732; hg19: chr22-36680714; API